Insider · CIK 0001417397

Basta Steven L

Reports to the SEC for 5 companies · FLORHAM PARK

sec.gov

Transactions

Companies

Filings

CIK

0001417397

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-10	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+12.4K sh	—	—	379,592
2026-02-10	PHATPhathom Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−6,277 sh	$12.82	−$80.5K	373,315
2026-01-02	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+251K sh	—	—	364,820
2026-01-02	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+226K sh	—	—	221,156
2025-12-17	PHATPhathom Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−31.5K sh	$15.36	−$484K	113,786
2025-12-17	PHATPhathom Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+62K sh	—	—	145,288
2025-12-12	YARWYarrow Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-11-28	PHATPhathom Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+90K sh	—	—	131,625
2025-11-28	PHATPhathom Pharmaceuticals, Inc. · Performance SharesM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−90K sh	—	—	180,000
2025-11-28	PHATPhathom Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−48.4K sh	$15.62	−$756K	83,250
2025-09-25	PHATPhathom Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+90K sh	—	—	90,000
2025-09-25	PHATPhathom Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−48.4K sh	$11.66	−$564K	41,625
2025-09-25	PHATPhathom Pharmaceuticals, Inc. · Performance SharesM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−90K sh	—	—	270,000
2025-04-03	PHATPhathom Pharmaceuticals, Inc. · Performance SharesA Award	Director, President and CEO	AAward	+360K sh	—	—	360,000
2025-04-03	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.09M sh	—	—	1,085,000
2024-12-12	YARWYarrow Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2024-01-01	YARWYarrow Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-12-13	YARWYarrow Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-01-03	VIVEVE MEDICAL, INC.Restricted Stock UnitA Award	Director	AAward	+72K sh	—	—	72,000
2022-08-10	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	Director	AAward	+20.5K sh	—	—	20,500
2022-01-04	VIVEVE MEDICAL, INC.Non-Qualified Stock Option (Right to Purchase)A Award	Director	AAward	+48K sh	—	—	48,000
2021-12-15	VIVEVE MEDICAL, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−28 sh	$1.41	−$39.48	25
2021-07-19	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	Director	AAward	+20.5K sh	—	—	20,500
2021-06-23	VIVEVE MEDICAL, INC.Non-Qualified Stock Option (Right to Purchase)A Award	Director	AAward	+116K sh	—	—	116,200
2021-01-20	VIVEVE MEDICAL, INC.Restricted Stock UnitA Award	Director	AAward	+50K sh	—	—	50,000
2020-09-21	VIVEVE MEDICAL, INC.Non-Qualified Stock Option (Right to Purchase)A Award	Director	AAward	+165K sh	—	—	165,000
2020-08-03	YARWYarrow Bioscience, Inc. · Stock OptionsA Award	Director	AAward	+22.5K sh	—	—	22,500
2020-04-03	YARWYarrow Bioscience, Inc.A Award	Director	AAward	+14.5K sh	—	—	536,537
2020-03-19	YARWYarrow Bioscience, Inc. · Stock OptionA Award	Director	AAward	+45K sh	—	—	45,000
2020-03-09	YARWYarrow Bioscience, Inc.A Award	Director	AAward	+7,108 sh	—	—	522,038
2019-12-11	YARWYarrow Bioscience, Inc.F Tax Payment	Director	FTax Payment	−85.2K sh	$4.52	−$385K	495,764
2019-12-11	YARWYarrow Bioscience, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14K sh	$1.83	+$25.6K	509,764
2019-12-11	YARWYarrow Bioscience, Inc.F Tax Payment	Director	FTax Payment	−85.2K sh	$4.52	−$385K	495,764
2019-12-11	YARWYarrow Bioscience, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+239K sh	—	—	580,974
2019-12-11	YARWYarrow Bioscience, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−239K sh	—	—	0
2019-12-11	YARWYarrow Bioscience, Inc. · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−14K sh	$1.83	−$25.6K	357,641
2019-12-11	YARWYarrow Bioscience, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−239K sh	—	—	0
2019-12-11	YARWYarrow Bioscience, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14K sh	$1.83	+$25.6K	509,764
2019-12-11	YARWYarrow Bioscience, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+239K sh	—	—	580,974
2019-12-11	YARWYarrow Bioscience, Inc. · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−14K sh	$1.83	−$25.6K	357,641
2019-11-26	VIVEVE MEDICAL, INC.Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+660K sh	—	—	660,000
2019-07-29	YARWYarrow Bioscience, Inc. · Restricted Stock UnitsA Award	Director	AAward	+239K sh	—	—	1,050,100
2019-07-29	YARWYarrow Bioscience, Inc. · Restricted Stock UnitsA Award	Director	AAward	+239K sh	—	—	1,050,100
2019-05-29	VIVEVE MEDICAL, INC.Non-Qualified Stock Option (Right to Purchase)A Award	Director	AAward	+35K sh	—	—	35,000
2019-04-01	VIVEVE MEDICAL, INC.A Award	Director	AAward	+24.2K sh	—	—	24,199
2019-01-15	VIVEVE MEDICAL, INC.Non-Qualified Stock Option (Right to Purchase)A Award	Director	AAward	+35K sh	—	—	35,000
2018-12-10	YARWYarrow Bioscience, Inc. · Stock OptionA Award	Director	AAward	+142K sh	—	—	141,900
2018-09-13	VIVEVE MEDICAL, INC.Non-Qualified Stock OptionsA Award	Director	AAward	+70K sh	—	—	70,000
2018-05-03	YARWYarrow Bioscience, Inc. · Stock OptionA Award	Director	AAward	+213K sh	—	—	669,400
2016-11-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,125 sh	$7.84	+$8,820	1,125

Recent filings

Accepted (ET)
Feb 124
Basta Steven L0001193125-26-048867
SEC(opens sec.gov)
Jan 24
Basta Steven L0001193125-26-001127
SEC(opens sec.gov)
Dec 194
Basta Steven L0001193125-25-327126
SEC(opens sec.gov)
Dec 154
Basta Steven L0001417397-25-000004
SEC(opens sec.gov)
Dec 24
Basta Steven L0001193125-25-305575
SEC(opens sec.gov)
Sep 264
Basta Steven L0001193125-25-220950
SEC(opens sec.gov)
Apr 34
Basta Steven L0000950170-25-050621
SEC(opens sec.gov)
Dec 134
Basta Steven L0001415889-24-029288
SEC(opens sec.gov)
Jan 34
Basta Steven L0001209191-24-000460
SEC(opens sec.gov)
Dec 154
Basta Steven L0001209191-23-058809
SEC(opens sec.gov)
Jan 54
Basta Steven L0001437749-23-000485
SEC(opens sec.gov)
Aug 124
Basta Steven L0001209191-22-045649
SEC(opens sec.gov)

Companies

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, 07932